Xenogeneic kidney transplantation from genetically modified pigs to Non-human primates represents a promising strategy to mitigate the global organ shortage crisis[Montgomery et al., 2022]. Nevertheless, hyperacute and acute rejection mechanisms, medi...
Xenogeneic kidney transplantation from genetically modified pigs to Non-human primates represents a promising strategy to mitigate the global organ shortage crisis[Montgomery et al., 2022]. Nevertheless, hyperacute and acute rejection mechanisms, mediated by both innate and adaptive immune responses, continue to impede successful long-term graft survival[O’Connell, 2005]. The relative contribution of innate immunity, particularly NK cell-mediated responses, to xenogeneic rejection remains incompletely characterized. [Chen et al., 2006].
In this study, I performed immunophenotypic analysis on PBMCs collected over time from xenotransplant recipients throughout the xenotransplantation period. Flow cytometry analysis revealed a correlation between T cell (CD3⁺), NK cell (NKG2D⁺), and IFN-γ-secreting cell populations and CRP concentration. Additionally, to confirm in vitro, human NK92mi cells and porcine kidney cells, PK15, were co-cultured to confirm the xenogeneic cell stimulation ability.
The analysis results showed that T cells and NK cells were suppressed in the early post-transplantation period (POD7) and recovered in the late transplantation period (Necropsy). In particular, IFN-γ⁺ cells were confirmed to increase as the late period (Necropsy) approached, and showed a high correlation with CRP concentration. In vitro experiments also confirmed that IFN-γ secretion by human NK cells in response to porcine kidney cell stimulation increased significantly over time.
This study confirmed that the immune response observed in xenotransplantation, despite the use of immunosuppressive agents to reduce immune rejection, was NK cell-mediated innate immune activation and IFN-γ-mediated inflammatory responses. These results highlight the importance of NK cells, like T cells, in modulating immune rejection in future xenotransplantation, providing a mechanistic basis for strategies targeting both innate and adaptive immunity.